SSZ-98 Molecular Sieve Synthesis Using Alternative Cations

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing molecular sieve SSZ-98 rely on N,N'-dimethyl-1,4-diazabicyclo[2.2.2]octane dications as structure directing agents, which may not be as effective or versatile as other cations in controlling the crystallization process.

Innovation Solution

The use of 1,1-diethylpyrrolidinium cations, 1-butyl-1-methylpiperidinium cations, 1,1-diethyl-4-methylpiperidinium cations, and 8-(pyridin-2-yl)-5,8-diazaspiro[4.5]decan-5-ium cations as structure directing agents in a reaction mixture comprising silicon oxide, aluminum oxide, a Group 1 or 2 metal, hydroxide ions, and water, under controlled crystallization conditions to form SSZ-98 crystals.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If N,N'-dimethyl-1,4-diazabicyclo[2.2.2]octane dications are used as structure directing agents, then molecular sieve SSZ-98 can be synthesized, but the synthesis effectiveness and versatility are limited

Engineering Contradiction:
Improveversatility of structure directing agentsVSAvoideffectiveness of crystallization control
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent changes the chemical parameters of the structure directing agent by replacing N,N'-dimethyl-1,4-diazabicyclo[2.2.2]octane dications with alternative cations including 1,1-diethylpyrrolidinium, 1-butyl-1-methylpiperidinium, 1,1-diethyl-4-methylpiperidinium, and 8-(pyridin-2-yl)-5,8-diazaspiro[4.5]decan-5-ium cations. This parameter change expands the versatility of available structure directing agents while maintaining their ability to effectively control the crystallization process and direct the formation of SSZ-98 molecular sieve with ERI framework topology.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If alternative cations are used as structure directing agents, then the versatility of synthesis methods is improved, but the complexity of selecting the appropriate cation increases

Engineering Contradiction:
Improvevariety of available structure directing agentsVSAvoidcomplexity of cation selection process
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent demonstrates that multiple different cation types can serve the same universal function of directing SSZ-98 crystallization. The alternative cations (1,1-diethylpyrrolidinium, 1-butyl-1-methylpiperidinium, 1,1-diethyl-4-methylpiperidinium, and 8-(pyridin-2-yl)-5,8-diazaspiro[4.5]decan-5-ium) all perform the same structure-directing role despite their structural differences, providing universality in function while expanding the range of available agents.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These alternative cations effectively direct the synthesis of SSZ-98, allowing for the production of molecular sieves with specific molar ratios and pore structures, enhancing the catalytic and adsorptive properties of the material.

Implementation Method 1

subjecting the reaction mixture to crystallization conditions sufficient to form crystals of the molecular sieve

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Data Source

PatentEP3442906B1Synthesis of molecular sieve SSZ-98
Publication Date: 2020.01.08 CHEVRON USA INC
  • EP3442906B1 patent drawingFigure 1
  • EP3442906B1 patent drawingFigure 2
  • EP3442906B1 patent drawing

AI summary

A method is disclosed for synthesizing molecular sieve SSZ-98 using a structure directing agent selected from one or more of 1,1-diethylpyrrolidinium cations, 1-butyl-1-methylpiperidinium cations, 1,1-diethyl-4-methylpiperidinium cations, and 8-(pyridin-2-yl)-5,8-diazaspiro[4.5]decan-5-ium cations.